Torrent Pharmaceuticals has reported results for first quarter ended June 30, 2024 (Q1FY25).
The company has reported 45.20% rise in its net profit at Rs 469 crore for the quarter ended June 30, 2024 as compared to Rs 323 crore for the same quarter in the previous year. Total income of the company increased by 15.34% at Rs 2,459 crore for Q1FY25 as compared to Rs 2,132 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 20.90% rise in net profit at Rs 457 crore for Q1FY25 as compared to Rs 378 crore for the same quarter in the previous year. Total income of the company increased by 9.83% at Rs 2,883 crore for Q1FY25 as compared to Rs 2,625 crore for the corresponding quarter previous year.
